RELATED CONTENT
NEWS
- Latest GetGoal positive for Sanofi/Zealand as European regulator mulls lixisenatide
- Amylin stock gains as more reports of potential buyers surface
- GSK's albiglutide GLP-1 agonist hits endpoint in a second PhIII trial
- Sanofi and Zealand impress with lixisenatide in latest GetGoal study
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

